Clinical trial

Reversing Type 1 Diabetes After it is Established

NCT01106157

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-04-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2010-04-01Date precision: month

Registry last updated2019-08-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

Anti-Thymocyte Globin (ATG)DRUG

Pegylated GCSFDRUG

Sponsors & collaborators

University of Floridalead sponsor

The Leona M. and Harry B. Helmsley Charitable Trustcollaborator

Genzyme, a Sanofi Companycollaborator

Mapped research locations

San FranciscoCalifornia, United States1 AuroraColorado, United States1 GainesvilleFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01106157 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.